United Therapeutics Corporation trailing returns
United Therapeutics Corporation's 10-year return is +16.5% a year (CAGR) (+358.8% cumulative). How United Therapeutics Corporation (UTHR) has performed over the last day, week, month and year, over 5, 10 and 20 years, and since inception, through October 2, 2026 — cumulative and annualized, with dividends on or off.
Trailing returns by period#
To 2026-10-02. Annualized (CAGR) for windows of a year or more.
| Period | Path | Annualized | Cumulative |
|---|---|---|---|
| 1 day | — | -5.2% | |
| 5 days | — | +13.9% | |
| 1 month | — | +10.1% | |
| YTD | — | +11.2% | |
| 1 year | +22.2% | +22.2% | |
| 5 years | +23.8% | +191.4% | |
| 10 years | +16.5% | +358.8% | |
| 20 years | +16.3% | +1952.3% | |
| Since inception (1999) | +17.9% | +8789.4% |
Growth of UTHR
Actual index level (solid); dashed lines are each window's constant-rate path from start to today.
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-10-02). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Total return reinvests dividends (from UTHR's split- and dividend-adjusted closes); price return excludes them. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
FAQ#
- What is United Therapeutics Corporation's 10-year return?
- Over the last 10 years, United Therapeutics Corporation (UTHR) returned about +16.5% a year annualized (+358.8% cumulative total return).
- What is United Therapeutics Corporation's 20-year annualized return?
- Over the last 20 years, United Therapeutics Corporation (UTHR) compounded at about +16.3% a year (+1952.3% cumulative).
- What is United Therapeutics Corporation's return since inception?
- Since 1999, United Therapeutics Corporation (UTHR) has compounded at about +17.9% a year — +8789.4% in total.